Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids.
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
There is much interest in defining the signals that initiate abnormal proliferation of cells in a variety of states characterized by the presence of mononuclear phagocytes. Since IL-1 is a major secretory product of activated human monocytes we examined whether this cytokine can stimulate the growth of human vascular smooth muscle cells (SMC). Neither recombinant IL-1 (rIL-1) alpha (less than or equal to 5.0 ng/ml) nor beta (less than or equal to 100 ng/ml) stimulated SMC growth during 2-d incubations under usual conditions. IL-1 did stimulate SMC to produce prostanoids such as PGE1 or PGE2 that can inhibit SMC proliferation. When prostaglandin synthesis was inhibited by indomethacin or aspirin both rIL-1 alpha and beta (greater than or equal to 1 ng/ml) markedly increased SMC growth. In longer-term experiments (7-28 d) rIL-1 stimulated the growth of SMC even in the absence of cyclooxygenase inhibitors. The addition of exogenous PGE1 or PGE2 (but not PGF1 alpha, PGF2 alpha, PGI2) to indomethacin-treated SMC blocked their mitogenic response to rIL-1. Antibody to IL-1 (but not to platelet-derived growth factor [PDGF]) abolished the mitogenic response of SMC to rIL-1. Exposure of SMC to rIL-1 or PDGF caused rapid (maximal at 1 h) and transient (baseline by 3 h) expression of the c-fos proto-oncogene, determined by Northern analysis. We conclude that IL-1 is a potent mitogen for human SMC. Endogenous prostanoid production simultaneously induced by IL-1 appears to antagonize this growth-promoting effect in the short term (2 d) but not during more prolonged exposures. IL-1 produced by activated monocytes at sites of tissue inflammation or injury may thus mediate both positive and negative effects on SMC proliferation that are temporally distinct.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Greenberg, M. E., & Ziff, E. B. (1984) · Nature · doi:10.1038/311433a0 · Cited by 3,064
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V., Gillis, S., Henney, C. S., Kronheim, S. R., Grabstein, K., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,579
Induction of c-fos gene and protein by growth factors precedes activation of c-myc
Müller, R., Bravo, R., Burckhardt, J., & Curran, T. (1984) · Nature · doi:10.1038/312716a0 · Cited by 1,369
The Pathogenesis of Atherosclerosis: (Second of Two Parts)
Ross, R., & Glomset, J. A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608192950805 · Cited by 1,163
Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Faggiotto, A., Ross, R., & Harker, L. (1984) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.4.4.323 · Cited by 984
Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein
Kruijer, W., Cooper, J. A., Hunter, T., & Verma, I. M. (1984) · Nature · doi:10.1038/312711a0 · Cited by 916
Dual control of cell growth by somatomedins and platelet-derived growth factor.
Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, H. N., Van Wyk, J. J., & Pledger, W. J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1279 · Cited by 909
Cited by
Prostaglandins and Inflammation
Ricciotti, E., & FitzGerald, G. A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207449 · Cited by 3,803
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Self-citationCytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Dinarello, C. A. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.2.3277884 · Cited by 1,532
Interleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
Ridker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002
The Role of Interleukin-1 in Disease
Epstein, F. H., Dinarello, C. A., & Wolff, S. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280207 · Cited by 954
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., & Cantley, L. C. (1989) · Cell · doi:10.1016/0092-8674(89)90182-7 · Cited by 908
Self-citationImmune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
Kornowski, R., Hong, M. K., Tio, F. O., Bramwell, O., Wu, H., & Leon, M. B. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00450-6 · Cited by 844
Inflammation and plaque vulnerability
Hansson, G. K., Libby, P., & Tabas, I. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12406 · Cited by 805
Self-citationRidker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Self-citationIp, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B., & Chesebro, J. H. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92845-s · Cited by 765
Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., & Ross, R. (1990) · Cell · doi:10.1016/0092-8674(90)90448-n · Cited by 741
Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AA
Raines, E. W., Dower, S. K., & Ross, R. (1989) · Science · doi:10.1126/science.2783498 · Cited by 646
Bussolino, F., Wang, J. M., Defilippi, P., Turrini, F., Sanavio, F., Edgell, C.-J. S., Aglietta, M., Arese, P., & Mantovani, A. (1989) · Nature · doi:10.1038/337471a0 · Cited by 633
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 619
Self-citationAmento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609
Self-citationElevation of C-reactive protein in “active” coronary artery disease
Berk, B. C., Weintraub, W. S., & Alexander, R. W. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90079-g · Cited by 588
Regulation of differentiated properties and proliferation of arterial smooth muscle cells.
Thyberg, J., Hedin, U., Sjölund, M., Palmberg, L., & Bottger, B. A. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.6.966 · Cited by 553
The Role of Oxidative Stress in Atherosclerosis
Batty, M., Bennett, M. R., & Yu, E. (2022) · Cells · doi:10.3390/cells11233843 · Cited by 536
Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging
Bucala, R., & Cerami, A. (1992) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60961-8 · Cited by 526
Cytokines as communication signals between leukocytes and endothelial cells
Mantovani, A., & Dejana, E. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90270-3 · Cited by 517
Immune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.567 · Cited by 515
Human vascular smooth muscle cells contain functional estrogen receptor.
Karas, R. H., Patterson, B. L., & Mendelsohn, M. E. (1994) · Circulation · doi:10.1161/01.cir.89.5.1943 · Cited by 489
Nuclear factor kappa-B and the heart
Valen, G., Yan, Z.-Q., & Hansson, G. K. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01377-8 · Cited by 447
Geng, Y.-J., Wu, Q., Muszynski, M., Hansson, G. K., & Libby, P. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.1.19 · Cited by 434
Self-citationOno, K., Matsumori, A., Shioi, T., Furukawa, Y., & Sasayama, S. (1998) · Circulation · doi:10.1161/01.cir.98.2.149 · Cited by 415
Cellular adhesion molecules and atherogenesis
Price, D. T., & Loscalzo, J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00153-9 · Cited by 388
Anti-inflammatory therapies for atherosclerosis
Bäck, M., & Hansson, G. K. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.5 · Cited by 378
Meydani, S. N., Lichtenstein, A. H., Cornwall, S., Meydani, M., Goldin, B. R., Rasmussen, H., Dinarello, C. A., & Schaefer, E. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116537 · Cited by 357
Manifestations of Human Cytomegalovirus Infection: Proposed Mechanisms of Acute and Chronic Disease
Britt, W. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-77349-8_23 · Cited by 345
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor
Takayama, K., Garcı́a-Cardeña, G., Sukhova, G. K., Comander, J., Gimbrone, M. A., & Libby, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204810200 · Cited by 337
Self-citationHypoxia But Not Inflammation Augments Glucose Uptake in Human Macrophages
Folco, E. J., Sheikine, Y., Rocha, V. Z., Christen, T., Shvartz, E., Sukhova, G. K., Di Carli, M. F., & Libby, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.044 · Cited by 326
Self-citationEpstein, F. H., & Hamerman, D. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905183202006 · Cited by 325
Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension
Jeffery, T. K., & Morrell, N. W. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.130041 · Cited by 317
Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease
Galea, J., Armstrong, J., Gadsdon, P., Holden, H., Francis, S. E., & Holt, C. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1000 · Cited by 310
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Shimokawa, H., Ito, A., Fukumoto, Y., Kadokami, T., Nakaike, R., Sakata, M., Takayanagi, T., Egashira, K., & Takeshita, A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118476 · Cited by 292
Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes.
Thaik, C. M., Calderone, A., Takahashi, N., & Colucci, W. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118095 · Cited by 272
The role of inflammation in vascular diseases
Sullivan, G. W., Sarembock, I. J., & Linden, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.5.591 · Cited by 271
Geng, Y.-J., Henderson, L. E., Levesque, E. B., Muszynski, M., & Libby, P. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2200 · Cited by 267
Self-citationSustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.
Tanaka, H., Sukhova, G. K., Swanson, S. J., Clinton, S. K., Ganz, P., Cybulsky, M. I., & Libby, P. (1993) · Circulation · doi:10.1161/01.cir.88.4.1788 · Cited by 265
Self-citationInterleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells.
Yue, T. L., Wang, X., Sung, C. P., Olson, B., McKenna, P. J., Gu, J. L., & Feuerstein, G. Z. (1994) · Circulation Research · doi:10.1161/01.res.75.1.1 · Cited by 260
Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
Gomez, D., Baylis, R. A., Durgin, B. G., Newman, A. A. C., Alencar, G. F., Mahan, S., St. Hilaire, C., Müller, W., Waisman, A., Francis, S. E., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0124-5 · Cited by 256
Serum albumin is a specific inhibitor of apoptosis in human endothelial cells
Zoellner, H., Höfler, M., Beckmann, R., Hufnagl, P., Vanyek, E., Bielek, E., Wojta, J., Fabry, A., Lockie, S., & Binder, B. R. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.10.2571 · Cited by 254
Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells
Yoshizumi, M., Kurihara, H., Morita, T., Yamashita, T., Oh-hashi, Y., Sugiyama, T., Takaku, F., Yanagisawa, M., Masaki, T., & Yazaki, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91948-r · Cited by 249
Differentiated Properties and Proliferation of Arterial Smooth Muscle Cells in Culture
Thyberg, J. (1996) · International Review of Cytology · doi:10.1016/s0074-7696(08)61987-7 · Cited by 239
Palmer, J. N., Hartogensis, W. E., Patten, M., Fortuin, F. D., & Long, C. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117956 · Cited by 203
“cluding both stimulation and inhibition of proliferation of both primary and transformed cells (44, 45, 57-59), including inter-”
BackgroundGuzman, L. A., Labhasetwar, V., Song, C., Jang, Y., Lincoff, A. M., Levy, R., & Topol, E. J. (1996) · Circulation · doi:10.1161/01.cir.94.6.1441 · Cited by 177
Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease
Aday, A. W., & Ridker, P. M. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00016 · Cited by 173
Holzman, L. B., Marks, R. M., & Dixit, V. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5830 · Cited by 172
Golej, D. L., Askari, B., Kramer, F., Barnhart, S., Vivekanandan-Giri, A., Pennathur, S., & Bornfeldt, K. E. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m013292 · Cited by 169
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications
Herder, C., Dalmas, E., Böni-Schnetzler, M., & Donath, M. Y. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.08.001 · Cited by 168
“Prospective studies usually control for a range of confirmed and potential confounders that may affect the association of Role of the IL-1 Pathway in Diabetes and Cardiovascular Disease (CVD): Evidence from Epidemiological Studies The relevance of the IL-1 pathway for T2D and its complications has been assessed not on…”
BackgroundBar-Shavit, R., Benezra, M., Eldor, A., Hy-Am, E., Fenton, J. W., Wilner, G. D., & Vlodavsky, I. (1990) · Cell Regulation · doi:10.1091/mbc.1.6.453 · Cited by 164
Primary Pulmonary Hypertension in HIV Patients: A Systematic Review
Pellicelli, A. M., Barbaro, G., Palmieri, F., Girardi, E., D'Ambrosio, C., Rianda, A., Barbarini, G., Frigiotti, D., Borgia, M. C., & Petrosillo, N. (2001) · Angiology · doi:10.1177/000331970105200105 · Cited by 114
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
Marhuenda, J., Medina, S., Martínez-Hernández, P., Arina, S., Zafrilla, P., Mulero, J., Oger, C., Galano, J.-M., Durand, T., Solana, A., et al. (2017) · Food Funct. · doi:10.1039/c7fo01081h · Cited by 22
Metadata
- Authors
- Libby, P., Warner, S. J., & Friedman, G. B.
- Venue
- Journal of Clinical Investigation
- Published
- 1988-02-01
- Volume
- 81
- Issue
- 2
- Pages
- 487-498
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2155291282
- Cited by
- 533
- References
- 59
- FWCI
- 35.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.